The loss of Laminin-α3 (Lama3) in higher-grade tumours (moderate dysplasia to invasive SCC) (Fig. 3a, c, Fig. 6a, Supplementary Fig. 2) could be used as a marker to predict metastatic behaviour. This evidence concerns the gene LAMA3 and neoplasm.